Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cannabidiol
Therapeutic Area : Technology
Study Phase : Undisclosed
Sponsor : Geocann
Deal Size : Undisclosed
Deal Type : Partnership
Cronos Group Partners with Geocann to Leverage VESIsorb Delivery Technology for Faster Absorption
Details :
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Undisclosed
June 27, 2022
Lead Product(s) : Cannabidiol
Therapeutic Area : Technology
Highest Development Status : Undisclosed
Sponsor : Geocann
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : Undisclosed
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : Ginkgo Bioworks
Deal Size : Undisclosed
Deal Type : Partnership
Cronos Group and Ginkgo Bioworks Announce Achievement of THCV Equity Milestone
Details :
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 21, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : Ginkgo Bioworks
Deal Size : Undisclosed
Deal Type : Partnership